← Study Library
In vitro · 2009
Preclinicalcounts toward this tierExogenous thymosin beta4 prevents apoptosis in human intervertebral annulus cells in vitro
Tapp H, Deepe R, Ingram JA, Yarmola EG, Bubb MR, Hanley EN Jr, Gruber HE · Biotechnic & Histochemistry
Preclinicalcounts toward this tier
Tβ4 at 800 nM significantly reduced the proportion of apoptotic annulus cells under both stresses (46.9% to 21.4% after peroxide, p = 0.044; 38.8% to 12.3% after serum starvation, p = 0.035), while 30 and 100 nM did not. Proteoglycan production was unchanged on both assay and histology and proliferation did not change — cell survival improved without any matrix response.
- Population
- Human intervertebral disc annulus cells from nine surgical patients, in monolayer and three-dimensional culture
- Intervention
- Exogenous thymosin β4 at 30 to 800 nM for 24 h before apoptosis was induced by hydrogen peroxide or serum starvation; 30 nM for 14 days in three-dimensional culture for matrix output
- Comparator
- Untreated cultures
- Limitations
- Culture study in disc fibrocartilage, not articular cartilage. The matrix test ran at 30 nM, a dose 27 times lower than the one that prevented apoptosis, so matrix synthesis at the dose that prevented apoptosis is untested. Funded by a hospital foundation, a back-pain research endowment, the Department of Veterans Affairs, NIAMS and the National Science Foundation.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental
Evidence for that entry
Preclinical